A new research paper was published in Oncotarget’s Volume 15 on April 8, 2024, entitled, “Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.”
Study shows GHRH antagonist’s role in AML drug resistance
- Post author:
- Post published:April 10, 2024
- Post category:uncategorized